Article Figures & Data
Tables
- Table 1
Comparing patient who have more knowledge with those who have less knowledge in regard to their demographics.
Table 1 N MSKQ score <60%N=90 (45%) Patient MSKQ score ≥60%N=110(55%) Patient Average MSKQ Score out of the 23 questions selected (±SD) Gender* (p-value=0.32) n (%) Male 68 (34) 32 (47.1) 36 (52.9) 13.19 (±4.10) Female 132 (66) 58 (43.9) 74 (56.1) 13.76 (±3.08) #Social status†‡ (p-value=0.51) n (%) Married 96 (48) 44 (45.8) 52 (54.2) 13.54 (±3.32) Single 86 (43) 36 (41.9) 50 (58.1) 13.77 (±3.56) Divorced 18 (9) 10 (55.6) 8 (44.4) 12.72 (±3.80) Age† (p-value=0.35) n (%) From 18-30 year 85 (42.5) 37 (43.5) 48 (56.5) 13.61 (±3.69) From 30-45 year 97 (48.5) 43 (44.3) 54 (55.7) 13.73 (±3.19) From 45-55 year 18 (9) 10 (55.6) 8 (44.4) 12.44 (±3.75) Educational level† (p-value=0.07) n (%) Less than high school 19 (9.5) 11 (57.9) 8 (42.1) 11.89 (±3.99) High school 52 (26) 28 (53.8) 24 (46.2) 13.08 (±3.50) Diploma 25 (12.5) 11 (44) 14 (56) 13.44 (±3.56) Bachelor 103 (51.5) 40 (38.8) 63 (61.2) 14.13 (±3.23) PhD 1 (0.5) 0 (0) 1 (100) 16 Occupation† (p value=0.003) n (%) Student 15 (7.5) 5 (33.3) 10 (66.7) 14.27 (±2.43) Teacher 32 (16) 8 (25) 24 (75) 14.72 (±3.27) Health care provider 14 (7) 2 (14.3) 12 (85.7) 16.29 (±2.84) Engineer 8 (4) 4 (50) 4 (50) 12.13 (±3.98) Military 7 (3.5) 4 (57.1) 3 (42.9) 11.86 (±4.71) Unemployed 99 (49.5) 54 (54.5) 45 (45.5) 13.03 (±3.28) Retired 6 (3) 4 (66.7) 2 (33.3) 11.33 (±4.76) Other 19 (9.5) 9 (47.4) 10 (52.6) 13.79 (±3.38) Residence† (p-value=0.28) n (%) Western region 41 (20.5) 15 (36.6) 26 (63.4) 13.98 (±3.47) Eastern region 43 (21.5) 21 (48.8) 22 (51.2) 12.88 (±3.37) Northern region 22 (11) 11 (50) 11 (50) 12.59 (±4.80) Sothern region 20 (10) 8 (40) 12 (60) 13.70 (±3.80) Central region 74 (37) 35 (47.3) 39 (52.7) 13.99 (±2.89) *Using T-test, † using one-way ANOVA, ‡ none of the participants were widowed Questions Contents MSKQ* Score (divided according to score%) Correct answer N=200(%) <60(%) 60 to <75(%) ≥75 (%) n=90 n=85 n=25 1 Organs involved in MS 78(86.7) 85(100)§ 23(92)§ 186(93)§ 2 CNS composition 51(56.7) 54(63.5) 16(64) 121(60.5) 4† MS impact on life expectancy 32(35.6) 66(77.6) 23(92)§ 121(60.5) 5 MS as immune disease 63(70) 71(83.5) 24(96)§ 158(79) 6 MS as a contagious disease 71(78.9) 85(100)§ 25(100)§ 181(90.5)§ 7 MS etiology 8(8.9)‡ 7(8.2)‡ 11(44) 26(13)‡ 8 MS transmission to offspring 43(47.8) 65(76.5) 21(84) 129(64.5) 9 MS transmission to other family member 9(10)‡ 18(21.2)‡ 15(60) 42(21)‡ 10 Myelin/axon damage 50(55.6) 71(83.5) 18(72) 139(69.5) 11 Age of onset 56(62.2) 76(89.4) 23(92)§ 155(77.5) 12 Sex ratio in MS prevalence 67(74.4) 80(94.1)§ 25(100)§ 172(86) 13 Myelin function 48(53.3) 72(84.7) 22(88) 142(71) 14 Tests used to diagnose MS 20(22.2)‡ 24(28.2) 13(52) 57(28.5) 15 Role of MRI in MS diagnosis 85(94.4)§ 83(97.6)§ 25(100)§ 193(96.5)§ 16 Role of gadolinium injections during MRI 7(7.8)‡ 17(20)‡ 13(52) 37(18.5)‡ 17 Role of MRI in disease follow up 62(68.9) 78(91.8)§ 25(100)§ 165(82.5) 18 Role of lumbar puncture 22(24.4)‡ 45(52.9) 22(88) 89(44.5) 19 Frequency of lumbar puncture 17(18.9)‡ 46(54.1) 21(84) 84(42) 21† Definition of remittent MS 13(14.4)‡ 43(50.6) 18(72) 74(37) 22 Benign MS 12(13.3)‡ 34(40) 19(76) 65(32.5) 23 Impact of pregnancy on MS 30(33.3) 73(85.9) 23(92)§ 126(63) 24 Curative treatment 74(82.2) 84(98.8)§ 24(96)§ 182(91)§ 25 Types of MS disease targeted by current therapies 25(27.8) 31(36.5) 13(52) 69(34.5) *MSKQ multiple sclerosis Knowledge questionnaire (taken with permission from Giordano et al. 2010), † question number 3 and 20 are deleted from the MSKQ (refer to text for explanation), (‡ = <25%, § = >90%)